Autopsy report · NCT00482066

Abatacept in ANCA Associated Vasculitis

“Funders withdrew funding due to slow recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 1 year before it stopped.
• 7 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Imperial College London

Sponsor type

University, hospital or other

Conditions

ANCA-associated Vasculitis

Interventions

Abatacept (Orencia)

Participants

7

Sites

1

Countries

United Kingdom

Trials that died the same way

• Paracetamol Versus Placebo in Conjunction With Strong Opioids for Cancer Pain
  “Funding was terminated early due to slow recruitment.” (76% match in meaning)
• Laser Assisted ICSI; Has it Role Whatsoever?
  “recruitment is stopped waiting for funds” (74% match in meaning)
• Cognitive Checking Intervention for Maladaptive Beliefs About Memory
  “Funding used up; recruitment slow.” (74% match in meaning)
• Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide
  “Low recruitment, sponsor withdrew funding.” (73% match in meaning)
• In Vivo Kinematics for Subjects Having a MicroPort Medial Pivot or DePuy Attune PCR TKA
  “Funding withdrawn, no participants recruited” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.